Literature DB >> 27877396

Bone formation in vivo induced by Cbfa1-carrying adenoviral vectors released from a biodegradable porous β-tricalcium phosphate (β-TCP) material.

Toshimasa Uemura1, Hiroko Kojima1.   

Abstract

Overexpression of Cbfa1 (a transcription factor indispensable for osteoblastic differentiation) is expected to induce the formation of bone directly and indirectly in vivo by accelerating osteoblastic differentiation. Adenoviral vectors carrying the cDNA of Cbfa1/til-1(Adv-Cbf1) were allowed to be adsorbed onto porous blocks of β-tricalcium phosphate (β-TCP), a biodegradable ceramic, which were then implanted subcutaneously and orthotopically into bone defects. The adenoviral vectors were released sustainingly by biodegradation, providing long-term expression of the genes. Results of the subcutaneous implantation of Adv-Cbfa1-adsorbed β-TCP/osteoprogenitor cells suggest that a larger amount of bone formed in the pores of the implant than in the control material. Regarding orthotopic implantation into bone defects, the released Adv-Cbfa1 accelerated regeneration in the cortical bone, whereas it induced bone resorption in the marrow cavity. A safer gene transfer using a smaller amount of the vector was achieved using biodegradable porous β-TCP as a carrier.

Entities:  

Keywords:  Cbfa1; DDS; adeno virus; β-TCP

Year:  2011        PMID: 27877396      PMCID: PMC5090468          DOI: 10.1088/1468-6996/12/3/034405

Source DB:  PubMed          Journal:  Sci Technol Adv Mater        ISSN: 1468-6996            Impact factor:   8.090


  15 in total

1.  Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering.

Authors:  Rachel M Schek; Erin N Wilke; Scott J Hollister; Paul H Krebsbach
Journal:  Biomaterials       Date:  2005-08-19       Impact factor: 12.479

2.  Ectopic osteogenesis of hBMP-2 gene-transduced human bone mesenchymal stem cells/BCB.

Authors:  Dong Han; Jianjun Li; Xiaoyi Guan
Journal:  Connect Tissue Res       Date:  2010-08       Impact factor: 3.417

3.  Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo.

Authors:  B J Mehrara; P B Saadeh; D S Steinbrech; M Dudziak; J A Spector; J A Greenwald; G K Gittes; M T Longaker
Journal:  J Bone Miner Res       Date:  1999-08       Impact factor: 6.741

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

6.  Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats.

Authors:  C Maniatopoulos; J Sodek; A H Melcher
Journal:  Cell Tissue Res       Date:  1988-11       Impact factor: 5.249

7.  Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene.

Authors:  A S Breitbart; D A Grande; J M Mason; M Barcia; T James; R T Grant
Journal:  Ann Plast Surg       Date:  1999-05       Impact factor: 1.539

8.  Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7.

Authors:  R T Franceschi; D Wang; P H Krebsbach; R B Rutherford
Journal:  J Cell Biochem       Date:  2000-06-06       Impact factor: 4.429

9.  In Vitro andIn Vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.

Authors:  S-L Cheng; J Lou; N M Wright; C F Lai; L V Avioli; K D Riew
Journal:  Calcif Tissue Int       Date:  2001-02       Impact factor: 4.333

10.  Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow-derived osteoprogenitor cells.

Authors:  Jian Dong; Toshimasa Uemura; Yoshio Shirasaki; Tetsuya Tateishi
Journal:  Biomaterials       Date:  2002-12       Impact factor: 12.479

View more
  1 in total

Review 1.  Current Trends in Viral Gene Therapy for Human Orthopaedic Regenerative Medicine.

Authors:  Jagadeesh Kumar Venkatesan; Ana Rey-Rico; Magali Cucchiarini
Journal:  Tissue Eng Regen Med       Date:  2019-02-21       Impact factor: 4.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.